Form 4 for DGX Quest Diagnostics
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001022079-24-000080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-01 | 2024-02-28 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $126.36 | -5,020 | 126.0K | -4% | -$634.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | F | D | 3,216 | $126.36 | 127,772 | D | — | — | (F1) Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. |
| 2 | Common | Common Stock | 2024-02-28 | F | D | 1,804 | $126.36 | 125,968 | D | — | — | (F1) Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. |